AI and rare diseases: a new frontier

At Web Summit Qatar, several biotech startups illustrated how artificial intelligence is helping to solve the challenges related to research and treatment of rare diseases. Automation, data analysis, and gene editing techniques, enhanced by AI, are opening new perspectives in a sector that often suffers from a lack of resources and expertise.

Automation and data analysis

The use of AI allows to automate complex processes and analyze large amounts of data, accelerating the discovery of potential drugs and therapies. This is particularly important in the case of rare diseases, where the scarcity of patients and data makes research more difficult and expensive.

Gene editing and AI

The integration of AI with gene editing techniques offers further opportunities for the development of personalized and targeted treatments. AI can help identify the most promising genetic targets and optimize intervention strategies.